Treatment to asthma is not as well distributed as we thought it was. Even when African-Americans patients were found to be the biggest group to visit the emergency department for asthma, 43% percent of them didn't want to see a doctor, finds a new study.
In the United States, there are persistent racial disparities in asthma prevalence, morbidity, and mortality. These disparities can largely be explained by looking at socioeconomic and environmental factors, such as access to healthcare, a nationwide analysis shows.
School-Based Therapy is Increasing for Asthma Treatment
Treating asthma symptoms when you first notice them is important. This will help prevent the symptoms from worsening and causing a severe asthma attack.
Advertisement
‘African Americans were found to have a substantially higher rate of emergency hospital visits for asthma and also for asthma-related death, compared with Caucasians.’
Tweet it Now
The findings highlight the potential of targeted interventions, such as mobile asthma clinic programs and joint programs with schools where asthma prevalence is high. Asthma is a leading cause of school absence.
The analysis was published Jan. 9 in the Journal of Allergy and Clinical Immunology.
Public health researchers have observed that African Americans have a substantially higher rate of emergency hospital visits for asthma and a higher rate of asthma-related death, compared with Caucasians.
![Novel Strategy for Better Asthma Treatment]( "Novel Strategy for Better Asthma Treatment")
Hindering the production of Interleukin-1, could alleviate the symptoms of asthma such as mucus, swelling and constriction.
"It isn't clear why asthma outcomes are worse in African American patients. The findings from our study suggest that poorer asthma outcomes are not genetic or biological in nature, but are instead due to a number of socioeconomic and environmental factors that impact asthma care," says Anne Fitzpatrick, Ph.D. "These factors can be modified and improved with the right interventions."
Fitzpatrick is associate professor of pediatrics and director of the Asthma Clinical Research Program in the Department of Pediatrics at Emory University School of Medicine.
A team of researchers led by Fitzpatrick analyzed data from the National Heart Lung and Blood Institute's Severe Asthma Research Program, which includes academic medical centers in California, Missouri, Wisconsin, Ohio, Georgia, North Carolina, Virginia, Pennsylvania, and Massachusetts. This study included 579 participants 6 years and older, each observed for one year.
For each participant, investigators took participants' medical histories, surveyed them about how they manage their asthma, and measured their lung function and other asthma biomarkers to gauge the severity of their asthma. Blood samples were also taken to look for sensitization to various allergens.
African American patients were more than twice as likely to visit the emergency department for asthma, the SARP data showed. When the statistics were weighted -- based on community and family socioeconomic factors and environmental exposure - the racial differences evened out.
What remained after the statistical weighting was that African American patients were 43 percent less likely to see a doctor in an outpatient setting for asthma.
When seeking to address asthma disparities, access to healthcare is one of the most important factors to consider, Fitzpatrick says. It can be difficult to schedule preventive medical services, and asthma medications can be quite expensive, even with adequate insurance coverage.
Allergenic housing conditions are another concern, she says. Asthma medications won't work well if triggers of asthma, such as dust mites and mold, aren't eliminated from the home.
Types of intervention that can make a difference are mobile asthma programs, often in coordination with schools, and employer-endorsed health initiatives that incentivize wellness and preventive care. A local example: the Ronald McDonald Care Mobile, launched in 2016 and now serving 11 elementary and middle schools in Atlanta public schools.
Source: Eurekalert
Novel Strategy for Better Asthma Treatment
Hindering the production of Interleukin-1, could alleviate the symptoms of asthma such as mucus, swelling and constriction.
Advertisement
"It isn't clear why asthma outcomes are worse in African American patients. The findings from our study suggest that poorer asthma outcomes are not genetic or biological in nature, but are instead due to a number of socioeconomic and environmental factors that impact asthma care," says Anne Fitzpatrick, Ph.D. "These factors can be modified and improved with the right interventions."
Fitzpatrick is associate professor of pediatrics and director of the Asthma Clinical Research Program in the Department of Pediatrics at Emory University School of Medicine.
A team of researchers led by Fitzpatrick analyzed data from the National Heart Lung and Blood Institute's Severe Asthma Research Program, which includes academic medical centers in California, Missouri, Wisconsin, Ohio, Georgia, North Carolina, Virginia, Pennsylvania, and Massachusetts. This study included 579 participants 6 years and older, each observed for one year.
For each participant, investigators took participants' medical histories, surveyed them about how they manage their asthma, and measured their lung function and other asthma biomarkers to gauge the severity of their asthma. Blood samples were also taken to look for sensitization to various allergens.
African American patients were more than twice as likely to visit the emergency department for asthma, the SARP data showed. When the statistics were weighted -- based on community and family socioeconomic factors and environmental exposure - the racial differences evened out.
What remained after the statistical weighting was that African American patients were 43 percent less likely to see a doctor in an outpatient setting for asthma.
When seeking to address asthma disparities, access to healthcare is one of the most important factors to consider, Fitzpatrick says. It can be difficult to schedule preventive medical services, and asthma medications can be quite expensive, even with adequate insurance coverage.
Allergenic housing conditions are another concern, she says. Asthma medications won't work well if triggers of asthma, such as dust mites and mold, aren't eliminated from the home.
Types of intervention that can make a difference are mobile asthma programs, often in coordination with schools, and employer-endorsed health initiatives that incentivize wellness and preventive care. A local example: the Ronald McDonald Care Mobile, launched in 2016 and now serving 11 elementary and middle schools in Atlanta public schools.
Source: Eurekalert
Indian Pharamaceutical Company Receives USFDA’s Nod for Asthma Treatment Drugs
Ajanta Pharma will soon launch its generic montelukast tablets and oral granules that helps in treating asthma and seasonal hay fever.
Advertisement
Asthma Treatment Less Effective in Middle-Aged and Older PatientsThe risk of asthma mortality increases in patients aged 30 and above, and the treatment failure rates increased proportionally with increasing age above 30. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
The model for memory consolidation claims that the hippocampus forms new memories and, as time goes on, trains the cortex to store enduring memories.
A new study explored the link between T immune cells in ill patients and mortality risk.
Limb savage procedure benefits patients with severe vascular disease who are at risk for amputation of their limbs.
Does omega-3 help Alzheimer's patients? A new form of omega-3 helped restore specific markers of eye health in mice bred with aspects of early-onset Alzheimer's disease.
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.